| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - CEO | - | SGX Company Announcements | ||
| Mo | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (ANG HAO YAO) | - | SGX Company Announcements | ||
| Mo | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (INTEGRAL LEAD LIMITED) | - | SGX Company Announcements | ||
| Mo | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (DRAGON GLORIOUS LIMITED) | - | SGX Company Announcements | ||
| Mo | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S) | - | SGX Company Announcements | ||
| Mo | ASIAMEDIC LIMITED: EMPLOYEE STOCK OPTION/SHARE SCHEME::ISSUE AND ALLOTMENT OF SHARES PURSUANT TO THE ASIAMEDIC ESOS 2016 | 1 | SGX Company Announcements | ||
| ASIAMEDIC Aktie jetzt für 0€ handeln | |||||
| 13.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 3 | SGX Company Announcements | ||
| 13.04. | ASIAMEDIC LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 1 | SGX Company Announcements | ||
| 13.04. | ASIAMEDIC LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::DISCREPANCIES BETWEEN UNAUDITED AND AUDITED ACCOUNTS | 1 | SGX Company Announcements | ||
| 13.04. | ASIAMEDIC LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 08.04. | ASIAMEDIC LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::RETIREMENT OF DIRECTOR | 1 | SGX Company Announcements | ||
| 06.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (INTEGRAL LEAD LIMITED) | - | SGX Company Announcements | ||
| 06.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (DRAGON GLORIOUS LIMITED) | - | SGX Company Announcements | ||
| 06.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (CAPITAL BLAZE LIMITED) | - | SGX Company Announcements | ||
| 06.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - SUBSTANTIAL SHAREHOLDER (ANG HAO YAO) | - | SGX Company Announcements | ||
| 06.04. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST /CHANGE IN INTEREST - CEO | - | SGX Company Announcements | ||
| 06.04. | ASIAMEDIC LIMITED: EMPLOYEE STOCK OPTION/SHARE SCHEME::ISSUE AND ALLOTMENT OF SHARES AND USE OF TREASURY SHARES PURSUANT TO THE ASIAMEDIC ESOS 2016 | 3 | SGX Company Announcements | ||
| 30.03. | ASIAMEDIC LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
| 01.03. | ASIAMEDIC LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS | - | SGX Company Announcements | ||
| 13.08.25 | AsiaMedic Limited: AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance | 358 | JCN Newswire | SINGAPORE, Aug 13, 2025 - (ACN Newswire) - SGX Catalist-listed AsiaMedic Limited (the "Company" and, together with its subsidiaries, the "Group") announced its unaudited financial results for the six... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 44,190 | +0,94 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
16.04.2026 /... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,530 | +0,63 % | Abspaltung der Siemens-Medizintechnik Healthineers erst im Jahr 2027 | DJ Abspaltung der Siemens-Medizintechnik erst im Jahr 2027
DOW JONES--Die Abspaltung der Siemens-Medizintechnik vom Mutterkonzern wird erst im nächsten Jahr stattfinden. Die Siemens-Aktionäre... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,580 | +0,38 % | Dax am Mittag leicht im Minus - FMC hinten | Frankfurt/Main - Der Dax hat sich am Mittwoch nach einem verhaltenen Start bis zum Mittag leicht in den roten Bereich gerutscht. Gegen 12:30 Uhr wurde der Leitindex mit rund 24.010 Punkten berechnet... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 47,830 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita | LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and... ► Artikel lesen | |
| BILLIONTOONE | 86,38 | 0,00 % | BillionToOne, Inc.: BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 | ||
| UNITEDHEALTH | 294,40 | +7,29 % | Earnings Preview: UnitedHealth, Tesla, Intel & Co.: Für diese Werte wird's jetzt spannend! | © Foto: Eduardo Munoz Alvarez/FR171643 AP/APDiese in den kommenden Tagen (KW17) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell eingepreisten... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,570 | 0,00 % | Wolfe Research stuft Alignment Healthcare mit "Outperform" ein | ||
| HEARTFLOW | 31,360 | 0,00 % | Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft | ||
| PROGYNY | 18,650 | 0,00 % | Progyny, Inc.: Progyny Expands Access to Fertility and Women's Health with Industry's First Fully Insured Supplemental Plan | ||
| CARL ZEISS MEDITEC | 28,180 | +1,22 % | Shortseller-Positionen aktuell: u.a. Auto1, Carl Zeiss Meditec, Evotec, Kontron, Puma, Renk, Verve, Zalando | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| GENEDX | 69,83 | 0,00 % | Jefferies bestätigt Kaufempfehlung für GeneDx und verweist auf geringe Marktdurchdringung | ||
| GERRESHEIMER | 21,960 | +3,49 % | Shortseller-Positionen aktuell: u.a. Delivery Hero, Gerresheimer, HelloFresh, Hugo Boss, Lanxess, Puma, Suss, Zalando | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| LIFEMD | 5,070 | 0,00 % | LifeMD, Inc.: LifeMD Now Offering Eli Lilly and Company's Foundayo (orforglipron), a New GLP-1 Pill for Weight Management | NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that it is now offering Foundayo (orforglipron) to eligible... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 25,720 | 0,00 % | PROCEPT BioRobotics: EAU Guidelines Upgrade Aquablation Therapy to Strong Surgical Recommendation for BPH | Updated European Association of Urology guidelines reflect growing clinical evidence supporting Aquablation therapy in the surgical treatment of benign prostatic hyperplasiaSAN JOSE, Calif., March 23... ► Artikel lesen | |
| HIMS & HERS HEALTH | 26,940 | +2,36 % | Hims & Hers-Aktie: Neue Chancen nach dem Hype? | Die Aktie von Hims & Hers Health hat nach einer Zeit voller Hype und überschwänglichen Erwartungen in den vergangenen Monaten massiv gelitten. Nach einem deutlichen Kursrückgang rückt nun die Frage... ► Artikel lesen |